治疗对高血压发病率的影响。舒张压平均为115至129毫米汞柱的患者的结果。 - Suppr

Suppr

超能文献

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

出版信息

JAMA. 1967 Dec 11;202(11):1028-34.

PMID:4862069

Abstract

摘要

相似文献

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

JAMA. 1967 Dec 11;202(11):1028-34.

Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.

Curr Ther Res Clin Exp. 1972 Sep;14(9):561-72.

[Influence of a combinated adelphan-esidrix and clonidin therapy on blood pressure and renal function in renal hypertension].

Dtsch Med Wochenschr. 1971 Aug 27;96(35):1380-3. doi: 10.1055/s-0028-1110146.

Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in Black and Indian hypertensive patients.

S Afr Med J. 1984 Jun 9;65(23):915-7.

A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.

Clin Ther. 1981;4(3):175-83.

[Experience in the treatment of increased blood pressure with a combination of dihydroergotoxine, reserpine and hydrochlorothiazide].

Med Pregl. 1984;37(3-4):131-5.

Propranolol in the treatment of essential hypertension.

JAMA. 1977 May 23;237(21):2303-10.

[Effects of short-term and long-term (5 years) administration of a new preparation for the treatment of arterial hypertension].

G Clin Med. 1976 Jan-Feb;57(1-2):46-65.

One-tablet combination drug therapy in the treatment of hypertension.

J Chronic Dis. 1972 Feb;25(2):57-64. doi: 10.1016/0021-9681(72)90141-5.

[Hemodynamics after intravenous administration of guanethidine, reserpine and hydrochlorothiazide].

Med Klin. 1967 Apr 14;62(15):600-4.

引用本文的文献

Height matters: re-thinking blood pressure targets through physics, physiology and evolution.

Clin Kidney J. 2025 Jul 18;18(8):sfaf226. doi: 10.1093/ckj/sfaf226. eCollection 2025 Aug.

Optimizing Nephron Performance: The Old, the New, and the New-Old Diuretic Therapies.

Biomedicines. 2025 Jun 9;13(6):1413. doi: 10.3390/biomedicines13061413.

Seven Deadly Sins in Hypertension Management: In-Depth Analysis of the Errors on a Journey from Riva-Rocci to Myocardial Fibrosis.

Arq Bras Cardiol. 2025 Apr;122(3):e20240811. doi: 10.36660/abc.20240811.

Clinical Trials in Hypertension: A Mathematical Endorsement for Diagnosis and Treatment.

Hypertension. 2025 Mar;82(3):411-418. doi: 10.1161/HYPERTENSIONAHA.124.21361. Epub 2024 Dec 31.

Balancing Affordability and Need: Should We Use Renal Denervation in Hypertension Management?

J Soc Cardiovasc Angiogr Interv. 2024 Aug 13;3(10):102248. doi: 10.1016/j.jscai.2024.102248. eCollection 2024 Oct.

Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019.

J Am Heart Assoc. 2024 Oct 15;13(20):e036557. doi: 10.1161/JAHA.124.036557. Epub 2024 Oct 11.

Exploring the Impact of Blood Pressure Variability on Incident Atrial Fibrillation in Type 2 Diabetes.

JACC Adv. 2023 Jun 30;2(4):100405. doi: 10.1016/j.jacadv.2023.100405. eCollection 2023 Jun.

[Not Available].

Arch Peru Cardiol Cir Cardiovasc. 2020 Mar 30;1(1):2-5. doi: 10.47487/apcyccv.v1i1.4. eCollection 2020 Jan-Mar.

In Search of Risk Factors: The Origin and Early Stages of Cardiovascular Epidemiology.

J Cardiovasc Dev Dis. 2024 Jan 12;11(1):20. doi: 10.3390/jcdd11010020.

Interactions Between Depression, Alcohol Intake, and Smoking on the Risk of Acute Coronary Syndrome.

Psychiatry Investig. 2024 Jan;21(1):1-8. doi: 10.30773/pi.2023.0245. Epub 2024 Jan 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验